JN Add DOIs to your references at manuscript stage!
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Neurophysiol 94: 2549-2560, 2005. First published June 22, 2005; doi:10.1152/jn.00339.2005
0022-3077/05 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
94/4/2549    most recent
00339.2005v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via ISI Web of Science (3)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Guo, J.-Z.
Right arrow Articles by Chiappinelli, V. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Guo, J.-Z.
Right arrow Articles by Chiappinelli, V. A.

Synaptically Released and Exogenous ACh Activates Different Nicotinic Receptors to Enhance Evoked Glutamatergic Transmission in the Lateral Geniculate Nucleus

Jian-Zhong Guo, Yingbing Liu, Eva M. Sorenson and Vincent A. Chiappinelli

Department of Pharmacology and Physiology, The George Washington University, School of Medicine and Health Sciences, Washington, DC

Submitted 31 March 2005; accepted in final form 13 June 2005

The effects of activation of nicotinic acetylcholine receptors (nAChRs) on glutamatergic transmission in the ventral lateral geniculate nucleus (LGNv) were examined in chick brain slices. Whole cell recordings showed that monosynaptic postsynaptic currents (PSCs) evoked in LGNv neurons by optic tract stimulation were blocked by glutamate receptor antagonists. Exogenously applied nicotine (0.5 µM), choline (1 mM), or acetylcholine (ACh, 100 µM) markedly increased (>3-fold) these evoked PSCs. Potentiation by ACh was dose-dependent and did not desensitize during a 5-min application. In a second set of experiments, the effect of releasing endogenous ACh by stimulating the lateral portion of the LGNv through a separate conditioning electrode before optic tract stimulation was examined. Conditioning stimulation trains increased PSCs by an average of 5.2-fold, an effect dependent on both the intensity and number of conditioning pulses. This increase in PSC amplitude was most likely caused by released ACh activating {alpha}6- and/or {alpha}3-containing nAChRs because it was blocked by 100 nM {alpha}-conotoxin MII, 100 nM dihydro-{beta}-erythroidine (DH{beta}E), and 0.1–1.0 µM methyllycaconitine (MLA). In contrast, exogenously applied ACh increased PSC amplitude by activating a pharmacologically different population of nAChRs because this effect was inhibited by 100 nM {alpha}-bungarotoxin, 50 nM MLA, and a high concentration (30 µM) of DH{beta}E, indicating that {alpha}7- and/or {alpha}8-containing receptors were involved. The results are consistent with a model whereby {alpha}6- and/or {alpha}3-containing nAChRs on retinal ganglion cell nerve terminals are located preferentially at cholinergic synapses, whereas {alpha}7- and/or {alpha}8-containing receptors are primarily extrasynaptic.


Address for reprint requests and other correspondence: J.-Z. Guo, Dept. of Pharmacology and Physiology, George Washington Univ., School of Medicine and Health Sciences, Suite 640, 2300 Eye St. NW, Washington, DC 20037 (E-mail: phmjzg{at}gwumc.edu)







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2005 by the The American Physiological Society.